Bendamustine 100 mg/20mL
Bendamustine HCl · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Meitheal Pharmaceuticals Inc.
Bendamustine is a injection, powder, lyophilized, for solution containing bendamustine hcl at 100 mg/20mL, taken intravenous. Manufactured by Meitheal Pharmaceuticals Inc..
Key Facts
- Brand Name
- Bendamustine
- Generic Name
- Bendamustine HCl
- NDC Code (Product)
71288-103- Manufacturer
- Meitheal Pharmaceuticals Inc.
- Strength
- 100 mg/20mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA211001
- Marketing Start
- 06/05/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Bendamustine used for?
Bendamustine contains Bendamustine HCl. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Bendamustine a controlled substance?
Bendamustine is not classified as a controlled substance by the DEA.
What is the generic name for Bendamustine?
The generic name for Bendamustine is Bendamustine HCl. There are no other listed brand versions of Bendamustine HCl.
What is the NDC code for Bendamustine 100 mg/20mL?
The NDC (National Drug Code) for Bendamustine 100 mg/20mL is 71288-103, listed by Meitheal Pharmaceuticals Inc..
Other Bendamustine Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)